Should your business consider launching a podcast? This communications expert says yes. Photo via Will Francis/Unsplash

As business leaders or marketers, we're always on the lookout for strategic opportunities to reach our target audiences in meaningful ways and move them to action: To like a post, ask for more information, make a purchase and more. When we put a lot of thought, energy and resources into marketing efforts, we want – and expect – a valuable return on that investment. Incorporating podcasting into your strategic marketing plan can help you realize that return.

A few years ago, KGBTexas Communications began producing thePoint, an online video series featuring conversations with innovative leaders from across Texas. The point of ThePoint is for these leaders to share insights into how they are working to create positive consequence in our communities. Our videos feature highlights of these conversations, and given the visual nature, this content is typically short and yes, to the point. However, different platforms engage audiences in different ways, and we saw podcasting as a natural progression to deepen engagement with our audience. We evolved thePoint into a podcast, More to thePoint, which serves as an extension of our video series with the goal of enhancing interaction with listeners by providing more in-depth information and conversation.

Through our experience, we have learned the value of utilizing the platform as an innovative tool to deepen connections with our audience as well as our community. Below are three reasons why businesses should consider incorporating podcasting into a marketing or communications plan.

Showcase your expertise

As a podcaster, you can position yourself as subject-matter expert. Diving deeply into relevant issues can make you a trusted voice that others come to for insight and advice. In this way, podcasting also serves as an organic advertisement for your business services, product, passion or mission. According to Jennifer Moxley, the founder of Sunshine Media Network, "Podcasts can make you relevant; they're a reason for someone to talk about you, share your social media content, invite you to guest panels or highlight you in your community."

Reach listeners authentically

According to Statista, a leading provider of market and consumer data, nearly 75% of podcast listeners tune in with the intent of learning something new. Listeners are choosing to connect with brands to receive valuable information. Additionally, the platform offers listeners the ability to tune in at their convenience, possibly while doing other things. Now you have the ability to connect with individuals while they drive to work, go for a walk or relax at home, rather than solely while they are visually connected to their computers or phones.

Low barrier of entry

In looking at a return on investment, podcasting can be a relatively inexpensive way to expand your marketing and engagement efforts. All you really need to start a podcast is a perspective, a guest, a microphone, (you can get a really good one for less than $200), and a hosting platform. Most hosting platforms will also provide you with statistics and data to help determine specific details about your audience, including the number of listeners, along with ages and locations. Knowing and understanding your audience is key, and podcasting can help businesses expand reach and track message reception at a low cost.

As a brand's authenticity and ability to connect with consumers becomes increasingly important for attracting and retaining customers, podcasting remains a largely untapped opportunity to build trust and strengthen relationships. When considering the low cost and high return, potential audience reach and boost to website traffic and SEO, it only makes sense to explore the benefits podcasting can bring to your business.

------

Katie Harvey is the CEO of KGBTexas Communications, one of the largest woman-owned, full-service agencies in Texas, with offices in San Antonio and Houston.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Texas tops ranking of best state for investors in new report

by the numbers

Texas ranks third on a new list of the best states for investors and startups.

Investment platform BrokerChooser weighed five factors to come up with its ranking:

  • 2024 Google search volume for terms related to investing
  • Number of investors
  • Number of businesses receiving investments in 2024
  • Total amount of capital invested in businesses in 2024
  • Percentage change in amount of investment from 2019 to 2024

Based on those figures, provided mostly by Crunchbase, Texas sits at No. 3 on the list, behind No. 1 California and No. 2 New York.

Especially noteworthy for Texas is its investment total for 2024: more than $164.5 billion. From 2019 to 2024, the state saw a 440 percent jump in business investments, according to BrokerChooser. The same percentages are 204 percent for California and 396 percent for New York.

“There is definitely development and diversification in the American investment landscape, with impressive growth in areas that used to fly under the radar,” says Adam Nasli, head analyst at BrokerChooser.

According to Crunchbase, funding for Texas startups is off to a strong start in 2025. In the first three months of this year, venture capital investors poured nearly $2.9 billion into Lone Star State companies, Crunchbase data shows. Crunchbase attributes that healthy dollar amount to “enthusiasm around cybersecurity, defense tech, robotics, and de-extincting mammoths.”

During the first quarter of this year, roughly two-thirds of VC funding in Texas went to just five companies, says Crunchbase. Those companies are Austin-based Apptronik, Austin-based Colossal Biosciences, Dallas-based Island, Austin-based NinjaOne, and Austin-based Saronic.

Autonomous truck company rolls out driverless Houston-Dallas route

up and running

Houston is helping drive the evolution of self-driving freight trucks.

In October, Aurora opened a more than 90,000-square-foot terminal at a Fallbrook Drive logistics hub in northwest Houston to support the launch of its first “lane” for driverless trucks—a Houston-to-Dallas route on the Interstate 45 corridor. Aurora opened its Dallas-area terminal in April and the company began regular driverless customer deliveries between the two Texas cities on April 27.

Close to half of all truck freight in Texas moves along I-45 between Houston and Dallas.

“Now, we are the first company to successfully and safely operate a commercial driverless trucking service on public roads. Riding in the back seat for our inaugural trip was an honor of a lifetime – the Aurora Driver performed perfectly and it’s a moment I’ll never forget,” Chris Urmson, CEO and co-founder of Pittsburgh-based Aurora, said in a news release.

Aurora produces software that controls autonomous vehicles and is known for its flagship product, the Aurora Driver. The software is installed in Volvo and Paccar trucks, the latter of which includes brands like Kenworth and Peterbilt.

Aurora previously hauled more than 75 loads per week under the supervision of vehicle operators from Houston to Dallas and Fort Worth to El Paso for customers in its pilot project, including FedEx, Uber Freight and Werner. To date, it has completed over 1,200 miles without a driver.

The company launched its new Houston to Dallas route with customers Uber Freight and Hirschbach Motor Lines, which ran supervised commercial pilots with Aurora.

“Transforming an old school industry like trucking is never easy, but we can’t ignore the safety and efficiency benefits this technology can deliver. Autonomous trucks aren’t just going to help grow our business – they’re also going to give our drivers better lives by handling the lengthier and less desirable routes,” Richard Stocking, CEO of Hirschbach Motor Lines, added in the statement.

The company plans to expand its service to El Paso and Phoenix by the end of 2025.

“These new, autonomous semis on the I-45 corridor will efficiently move products, create jobs, and help make our roadways safer,” Gov. Greg Abbott added in the release. “Texas offers businesses the freedom to succeed, and the Aurora Driver will further spur economic growth and job creation in Texas. Together through innovation, we will build a stronger, more prosperous Texas for generations.”

In July, Aurora said it raised $820 million in capital to fuel its growth—growth that’s being accompanied by scrutiny.

In light of recent controversies surrounding self-driving vehicles, the International Brotherhood of Teamsters, whose union members include over-the-road truckers, recently sent a letter to Lt. Gov. Dan Patrick calling for a ban on autonomous vehicles in Texas.

“The Teamsters believe that a human operator is needed in every vehicle—and that goes beyond partisan politics,” the letter states. “State legislators have a solemn duty in this matter to keep dangerous autonomous vehicles off our streets and keep Texans safe. Autonomous vehicles are not ready for prime time, and we urge you to act before someone in our community gets killed.”

Houston cell therapy company launches second-phase clinical trial

fighting cancer

A Houston cell therapy company has dosed its first patient in a Phase 2 clinical trial. March Biosciences is testing the efficacy of MB-105, a CD5-targeted CAR-T cell therapy for patients with relapsed or refractory CD5-positive T-cell lymphoma.

Last year, InnovationMap reported that March Biosciences had closed its series A with a $28.4 million raise. Now, the company, co-founded by Sarah Hein, Max Mamonkin and Malcolm Brenner, is ready to enroll a total of 46 patients in its study of people with difficult-to-treat cancer.

The trial will be conducted at cancer centers around the United States, but the first dose took place locally, at The University of Texas MD Anderson Cancer Center. Dr. Swaminathan P. Iyer, a professor in the department of lymphoma/myeloma at MD Anderson, is leading the trial.

“This represents a significant milestone in advancing MB-105 as a potential treatment option for patients with T-cell lymphoma who currently face extremely limited therapeutic choices,” Hein, who serves as CEO, says. “CAR-T therapies have revolutionized the treatment of B-cell lymphomas and leukemias but have not successfully addressed the rarer T-cell lymphomas and leukemias. We are optimistic that this larger trial will further validate MB-105's potential to address the critical unmet needs of these patients and look forward to reporting our first clinical readouts.”

The Phase 1 trial showed promise for MB-105 in terms of both safety and efficacy. That means that potentially concerning side effects, including neurological events and cytokine release above grade 3, were not observed. Those results were published last year, noting lasting remissions.

In January 2025, MB-105 won an orphan drug designation from the FDA. That results in seven years of market exclusivity if the drug is approved, as well as development incentives along the way.

The trial is enrolling its single-arm, two-stage study on ClinicalTrials.gov. For patients with stubborn blood cancers, the drug is providing new hope.